Evidence map›Paper›PMID 27712034›Full record

Observational studyJournal of diabetes investigation2017

Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient- and physician-related factors): A prospective observational DIPP-FACTOR study in Korea.

Sin Gon Kim, Nam Hoon Kim, Bon Jeong Ku, Ho Sang Shon, Doo Man Kim, Tae Sun Park, Yong-Seong Kim, In Joo Kim, Dong Seop Choi

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of diabetes investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Sin Gon KimDivision of Endocrinology, Korea University Anam Hospital, Seoul, Korea.
Nam Hoon KimDivision of Endocrinology, Korea University Anam Hospital, Seoul, Korea.
Bon Jeong KuDepartment of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.ORCID http://orcid.org/0000-0002-3414-8949
Ho Sang ShonDivision of Endocrinology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
Doo Man KimDivision of Endocrinology, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea.
Tae Sun ParkDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.
Yong-Seong KimDivision of Endocrinology & Metabolism, Department of Internal Medicine, Inha University Incheon, Incheon, Korea.
In Joo KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.
Dong Seop ChoiDivision of Endocrinology, Korea University Anam Hospital, Seoul, Korea.
Korea University Medical Center · KRChungnam National University Hospital · KRDaegu Catholic University · KRHallym University · KRIncheon National University · KRJeonbuk National University · KRPusan National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionTo assess the time to initiation of insulin therapy, and concurrently investigate both patient- and physician-related factors associated with delaying insulin therapy in Korean patients with type 2 diabetes uncontrolled by oral hypoglycemic agents (OHAs). MATERIALS AND

methodsThis prospective, observational disease registry study was carried out across 69 centers in Korea. Type 2 diabetes patients who had received two or more OHAs within the past 5 years, had a glycated hemoglobin ≥8% in the past 6 months and had not received insulin were included. Data recorded on data collection forms during a 12-month period were analyzed.

resultsOf 2168 patients enrolled, 1959 were evaluated and classified as the insulin-initiated or insulin-delayed group. Insulin was prescribed for just 20% of the patients during a 1-year follow-up period, and less than half (44.5%) of the patients who were taking two OHAs started insulin after 6 years. Patient-related factors for delay in insulin initiation included older age, shorter duration of diabetes and lower glycated hemoglobin. Physician-related factors included age (~50 to <60 years), sex (women) and number (<1000) of patients consulted per month. Patient refusal (33.6%) and physicians' concerns of patient non-compliance (26.5%) were the major physician-reported reasons for delaying insulin therapy. Inconvenience of insulin therapy (51.6%) and fear of injection (48.2%) were the major reasons for patient refusal.

conclusionsInsulin initiation is delayed in patients with type 2 diabetes uncontrolled by two or more OHAs in Korea. Patient- and physician-related factors associated with this delay need to be addressed for better diabetes management.

Indexed as

Physician-Patient RelationsAdministration, OralAdultDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsInsulinMaleMiddle AgedPatient ParticipationProspective StudiesRegistriesRepublic of KoreaHypoglycemic AgentsInsulinInsulin therapyPhysician and patient behaviorsType 2 diabetes

Identifiers

PMID27712034
PMCPMC5415458
OpenAlexW2529143605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.